BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 23392438)

  • 41. An integrated index combined by dynamic hyperinflation and exercise capacity in the prediction of morbidity and mortality in COPD.
    Ozgür ES; Nayci SA; Özge C; Taşdelen B
    Respir Care; 2012 Sep; 57(9):1452-9. PubMed ID: 22348294
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Trends in Prevalence and Prognosis in Subjects With Acute Chronic Respiratory Failure Treated With Noninvasive and/or Invasive Ventilation.
    Gacouin A; Jouneau S; Letheulle J; Kerjouan M; Bouju P; Fillatre P; Le Tulzo Y; Tadié JM
    Respir Care; 2015 Feb; 60(2):210-8. PubMed ID: 25406346
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
    Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
    JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chronic obstructive pulmonary disease in non-smokers: a case-comparison study.
    Sexton P; Black P; Wu L; Sommerville F; Hamed M; Milne D; Metcalf P; Kolbe J
    COPD; 2014 Feb; 11(1):2-9. PubMed ID: 23844977
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Emphysema presence, severity, and distribution has little impact on the clinical presentation of a cohort of patients with mild to moderate COPD.
    de Torres JP; Bastarrika G; Zagaceta J; Sáiz-Mendiguren R; Alcaide AB; Seijo LM; Montes U; Campo A; Zulueta JJ
    Chest; 2011 Jan; 139(1):36-42. PubMed ID: 20705800
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of chronic obstructive pulmonary disease severity on surgical outcomes in patients undergoing non-emergent coronary artery bypass grafting.
    Saleh HZ; Mohan K; Shaw M; Al-Rawi O; Elsayed H; Walshaw M; Chalmers JA; Fabri BM
    Eur J Cardiothorac Surg; 2012 Jul; 42(1):108-13; discussion 113. PubMed ID: 22290913
    [TBL] [Abstract][Full Text] [Related]  

  • 47. External validation of multidimensional prognostic indices (ADO, BODEx and DOSE) in a primary care international cohort (PROEPOC/COPD cohort).
    Espantoso-Romero M; Román Rodríguez M; Duarte-Pérez A; Gonzálvez-Rey J; Callejas-Cabanillas PA; Lazic DK; Anta-Agudo B; Torán Monserrat P; Magallon-Botaya R; Gerasimovska Kitanovska B; Lingner H; Assenova RS; Iftode C; Gude-Sampedro F; Clavería A;
    BMC Pulm Med; 2016 Nov; 16(1):143. PubMed ID: 27835945
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bronchiectasis as a Comorbidity of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis.
    Du Q; Jin J; Liu X; Sun Y
    PLoS One; 2016; 11(3):e0150532. PubMed ID: 26978269
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of chronic obstructive pulmonary disease on survival and symptoms of severe aortic valve stenosis.
    Poulsen MK; Dahl JS; Kjeldsen BJ; Nørregaard-Hansen K; Pedersen KE; Mickley H; Nissen H
    Scand Cardiovasc J; 2015 Feb; 49(1):49-55. PubMed ID: 25658150
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of bronchiectasis on the exacerbation and mortality of chronic obstructive pulmonary disease.
    Fendoğlu TZ; Köktürk N; Yapar D; Kılıç P; Kılıç K; Erbaş G
    Clin Respir J; 2021 Oct; 15(10):1113-1120. PubMed ID: 34224649
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Coronary artery calcification, epicardial fat burden, and cardiovascular events in chronic obstructive pulmonary disease.
    Gaisl T; Schlatzer C; Schwarz EI; Possner M; Stehli J; Sievi NA; Clarenbach CF; Dey D; Slomka PJ; Kaufmann PA; Kohler M
    PLoS One; 2015; 10(5):e0126613. PubMed ID: 26011039
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chest CT-assessed comorbidities and all-cause mortality risk in COPD patients in the BODE cohort.
    Ezponda A; Casanova C; Divo M; Marín-Oto M; Cabrera C; Marín JM; Bastarrika G; Pinto-Plata V; Martin-Palmero Á; Polverino F; Celli BR; de Torres JP
    Respirology; 2022 Apr; 27(4):286-293. PubMed ID: 35132732
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk of mortality from cardiovascular and respiratory causes in patients with chronic obstructive pulmonary disease submitted to follow-up after lung resection for non-small cell lung cancer.
    Volpino P; Cangemi R; Fiori E; Cangemi B; De Cesare A; Corsi N; Di Cello T; Cangemi V
    J Cardiovasc Surg (Torino); 2007 Jun; 48(3):375-83. PubMed ID: 17505444
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2007 and 2011 staging systems: a pooled analysis of individual patient data.
    Soriano JB; Lamprecht B; Ramírez AS; Martinez-Camblor P; Kaiser B; Alfageme I; Almagro P; Casanova C; Esteban C; Soler-Cataluña JJ; de-Torres JP; Miravitlles M; Celli BR; Marin JM; Puhan MA; Sobradillo P; Lange P; Sternberg AL; Garcia-Aymerich J; Turner AM; Han MK; Langhammer A; Leivseth L; Bakke P; Johannessen A; Roche N; Sin DD
    Lancet Respir Med; 2015 Jun; 3(6):443-50. PubMed ID: 25995071
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognosis of heart failure patients with reduced and preserved ejection fraction and coexistent chronic obstructive pulmonary disease.
    Kwon BJ; Kim DB; Jang SW; Yoo KD; Moon KW; Shim BJ; Ahn SH; Cho EJ; Rho TH; Kim JH
    Eur J Heart Fail; 2010 Dec; 12(12):1339-44. PubMed ID: 20861127
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The progression of chronic obstructive pulmonary disease is heterogeneous: the experience of the BODE cohort.
    Casanova C; de Torres JP; Aguirre-Jaíme A; Pinto-Plata V; Marin JM; Cordoba E; Baz R; Cote C; Celli BR
    Am J Respir Crit Care Med; 2011 Nov; 184(9):1015-21. PubMed ID: 21836135
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Longitudinal changes in clinical outcomes in older patients with asthma, COPD and asthma-COPD overlap syndrome.
    Fu JJ; Gibson PG; Simpson JL; McDonald VM
    Respiration; 2014; 87(1):63-74. PubMed ID: 24029561
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Bronchial dilatations in patients with chronic obstructive pulmonary disease in a Tunisian center: effect on disease progression and prognosis].
    Saad AB; Migaou A; Mhamed SC; Fahem N; Rouatbi N; Joobeur S
    Pan Afr Med J; 2020; 37():200. PubMed ID: 33505569
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of β-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary disease.
    Kubota Y; Asai K; Furuse E; Nakamura S; Murai K; Tsukada YT; Shimizu W
    Int J Chron Obstruct Pulmon Dis; 2015; 10():515-23. PubMed ID: 25784798
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome.
    Marin JM; Soriano JB; Carrizo SJ; Boldova A; Celli BR
    Am J Respir Crit Care Med; 2010 Aug; 182(3):325-31. PubMed ID: 20378728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.